GE HealthCare Technologies Inc. (NASDAQ:GEHC) Holdings Raised by Korea Investment CORP

Korea Investment CORP lifted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 58.1% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 294,622 shares of the company's stock after buying an additional 108,300 shares during the period. Korea Investment CORP owned 0.06% of GE HealthCare Technologies worth $23,034,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. CoreFirst Bank & Trust bought a new position in shares of GE HealthCare Technologies during the fourth quarter worth about $25,000. Runnymede Capital Advisors Inc. bought a new position in GE HealthCare Technologies in the 4th quarter worth about $28,000. Continuum Advisory LLC grew its position in GE HealthCare Technologies by 101.8% in the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company's stock worth $31,000 after purchasing an additional 168 shares during the last quarter. Bank of Jackson Hole Trust bought a new stake in shares of GE HealthCare Technologies during the fourth quarter valued at approximately $32,000. Finally, OFI Invest Asset Management acquired a new position in shares of GE HealthCare Technologies during the fourth quarter worth approximately $34,000. Institutional investors and hedge funds own 82.06% of the company's stock.

GE HealthCare Technologies Trading Down 11.1 %

GEHC traded down $8.78 during trading on Thursday, reaching $70.58. The company had a trading volume of 3,285,484 shares, compared to its average volume of 2,945,350. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. GE HealthCare Technologies Inc. has a 12-month low of $70.49 and a 12-month high of $94.80. The company has a market cap of $32.28 billion, a price-to-earnings ratio of 16.30, a PEG ratio of 3.19 and a beta of 1.13. The firm's 50-day simple moving average is $86.30 and its 200 day simple moving average is $85.71.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The business had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. Equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be issued a $0.035 dividend. The ex-dividend date is Friday, April 25th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.20%. GE HealthCare Technologies's payout ratio is currently 3.23%.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. The Goldman Sachs Group upgraded GE HealthCare Technologies from a "neutral" rating to a "buy" rating and boosted their price target for the stock from $85.00 to $100.00 in a research report on Tuesday, March 11th. Jefferies Financial Group raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and upped their price objective for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Wells Fargo & Company raised their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a research note on Friday, February 14th. Finally, Citigroup upped their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a research note on Thursday, February 13th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $97.73.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.